Financial toxicity as logistical and relational burden across the lifespan during autologous transplant preparation

Category	Detail
Condition	Multiple Myeloma
Key Mechanisms	Financial toxicity affecting treatment preparation and decision-making.
Target Population	Patients preparing for autologous stem cell transplant (ASCT), particularly older adults.
Care Setting	Cancer care centers, specifically during ASCT preparation.

Financial toxicity significantly impacts treatment readiness and decision-making.
Patients often experience indirect expressions of financial strain, such as work disruption and caregiver burden.
Nearly half of patients undergoing ASCT report meaningful financial hardship.
Financial toxicity is linked to worse health-related quality of life and mental health outcomes.
Qualitative insights reveal financial concerns are often minimized or deferred in clinical settings.

Consider the psychosocial impacts of financial toxicity on treatment adherence and quality of life.

Patients with multiple myeloma preparing for ASCT, including older adults.

Financial considerations are intertwined with treatment decisions and caregiver availability.

Incorporate discussions of financial toxicity into patient education and care planning.
Support caregivers to mitigate the financial and emotional burdens associated with ASCT preparation.
Utilize qualitative data to understand the lived experiences of patients regarding financial toxicity.

Clinical Scorecard: The Impact of Financial Toxicity on Logistical and Relational Challenges Throughout the Lifespan in Autologous Stem Cell Transplant Preparation